Montico, Barbara
Colizzi, Francesca
Giurato, Giorgio
Rizzo, Aurora
Salvati, Annamaria
Baboci, Lorena
Benedetti, Dania
Pivetta, Eliana http://orcid.org/0000-0001-5481-5713
Covre, Alessia
Bo, Michele Dal
Weisz, Alessandro
Steffan, Agostino
Maio, Michele
Sigalotti, Luca
Fratta, Elisabetta http://orcid.org/0000-0002-7472-8841
Funding for this research was provided by:
Ministero della Salute Ricerca Corrente, 5x1000 Intramural Grant from CRO
Italian Melanoma Intergroup (IMI) "Simone Acquistapace" fellowship
Associazione Italiana per la Ricerca sul Cancro (IG-17426)
Ministero dell’Università e della Ricerca
Article History
Received: 8 November 2019
Revised: 5 May 2020
Accepted: 5 May 2020
First Online: 22 May 2020
Conflict of interest
: M.M. is a consultant/advisory board member for Bristol-Meyers Squibb, Incyte, MSD Oncology, Roche, Astex Pharmaceuticals, Amgen, AstraZeneca, and Merck Serono. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.